Frequency and avoidability of lethal undesirable drugs effects;Zur Häufigkeit und Vermeidbarkeit von tödlichen unerwünschten Arzneimittelwirkungen

Internist

Volumn 44, Issue 7, 2003, Pages 889-895

  Schnurrer, J U ^b   Frolich J C ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

Fatal casualties; Pharmaceutical agents; Prescription errors; Side effects; Undesirable drug effects

Indexed keywords

ANTIBIOTIC AGENT; ANTIDIABETIC AGENT; ANTIINFECTIVE AGENT; FUROSEMIDE; GLIBENCLAMIDE; PREDNISOLONE; SULFONAMIDE; THIAZIDE DIURETIC AGENT;

COMPUTER SYSTEM; DRUG FATALITY; EXPERT SYSTEM; GERMANY; HUMAN; INCIDENCE; PRESCRIPTION; REVIEW;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CLINICAL PHARMACY INFORMATION SYSTEMS; DRUG THERAPY, COMPUTER-ASSISTED; GERMANY; HUMANS; INCIDENCE; MEDICATION ERRORS; NORWAY; PHARMACOLOGY; RISK ASSESSMENT; SURVIVAL RATE;

EID: 20244363896     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-003-0988-3     Document Type: Review

References (46)

1. World Health Organisation (1969) International drug monitoring. The role of hospital. Technical Report Series No. 425
2. World Health Organisation (1972) International drug monitoring. The role of national centres. Technical Report Series No. 498
3. Bates DW et al. (1995) Incidence of adverse drug events and potential adverse drug events. Implications for prevention. JAMA 274:29-34
4. van den Bemt PM et al. (2000) Drug-related problems in hospitalised patients. Drug Saf 22: 321-333
5. Jha AK et al. (1998) Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc 5: 305-314
6. Bates DW et al. (1997)The costs of adverse drug events in hospitalized patients. JAMA 277: 307-311
7. Bates DW, Leape LL, Petrycki S (1993) Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med 8: 289-294
8. Easton KL et al. (1998) The incidence of drug-related problems as a cause of hospital admissions in children. Med J Aust 169: 356-359
9. Lakshmanan MC, Hershey CO, Breslau D (1986) Hospital admissions caused by iatrogenic disease. Arch Intern Med 146: 1931-1934
10. Dartnell JG et al. (1996) Hospitalisation for adverse events related to drug therapy: incidence, avoid ability and costs. Med J Aust 164: 659-662
11. Bero LA, Lipton HL, Bird JA (1991) Characterization of geriatric drug-related hospital readmissions. Med Care 29: 989-1003
12. Classen DC et al. (1997) Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 277: 301-306
13. Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a metaanalysis of prospective studies. JAMA 279: 1200-1205
14. Wille H, Schönhöfer PS (2002) Arzneimittelsicherheit und Nachkontrolle. Internist 43: 469-481
15. Caranasos GJ, Stewart BB, Cluff LE (1974) Drug-induced illness leading to hospitalization. JAMA 228: 713-717
16. Miller RR (1973) Drug surveillance utilizing epidemiologic methods. A report from the Boston Collaborative Drug Surveillance Program. Am J Hosp Pharm 30: 584-592
17. Bates DW et al. (1995) Relationship between medication errors and adverse drug events. J Gen Intern Med 10: 199-205
18. Mitchell AA et al. (1988) Adverse drug reactions in children leading to hospital admission. Pediatrics 82: 24-29
19. Ebbesen J et al. (2001) Drug-related deaths in a department of internal medicine. Arch Intern Med 161: 2317-2323
20. Buajordet, I et al. (2001) Fatal adverse drug events: the paradox of drug treatment. J Intern Med 250: 327-341
21. Arnold M, Litsch M, Schwartz FW (1999) Krankenhaus - Report 99. Schattauer, Stuttgart New York
22. Schönhöfer PS (1999) Klinik-basierte Erfassung Arzneimittel-bedingter Erkrankungen im Pharmakovigilanz-System (ZKH Bremen). Arzneimitteltherapie 17: 83-86
23. Leape LL et al. (1995) Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA 274: 35-43
24. Bates DW (1999) Frequency, consequences and prevention of adverse drug events. J Qual Clin Pract 19: 13-17
25. Lesar TS, Briceland L, Stein DS (1997) Factors related to errors in medication prescribing. JAMA 277: 312-317
26. Lindquist R, Gersema LM (1998) Understanding and preventing adverse drug events. AACN Clin Issues 9: 119-128
27. Rolfe S, Harper NJ (1995) Ability of hospital doctors to calculate drug doses. BMJ 310: 1173-1174
28. Frölich JC, Kirch W (2000) Praktische Arzneitherapie, 2. Aufl. Springer, Berlin Heidelberg New York
29. Mutschler E et al. (2001) Arzneimittelwirkungen, 8. Aufl. Wiss.-Verlagsges., Stuttgart
30. Wrenger E et al. (2003) Lesson of the week - Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers causing life threatening hyperkaliämia: analysis of 43 cases. BMJ (in press)
31. Kohn LT, Corrigan JM, Donaldson MS (1999) To err is human. Committee on Quality Health Care in America, Institute of Medicine. National Academy Press, Washington
32. Frölkh JC (2001) Die Hälfte aller Arzneinebenwirkungen wäre vermeidbar! med-online: 3
33. Troost R et al. (1999) Arzneimittelinformation - eine Aufgabe der Klinischen Pharmakologie. Niedersächs Ärztebl: 16-18
34. Lumpe M et al. (1998) Individualisierte Arzneimittel information. Dtsch Ärztebl 95: 3053-3056
35. Bates DW et al. (1998) Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 280: 1311-1316
36. Teich JM et al. (2000) Effects of computerized physician order entry on prescribing practices. Arch Intern Med 160: 2741-2747
37. Overhage JM et al. (1997) A randomized trial "of corollary orders" to prevent errors of omission. J Am Med Inform Assoc 4: 364-375
38. Bates DW et al. (1999) The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc 6: 313-321
39. Bates DW (2000) Using information technology to reduce rates of medication errors in hospitals. BMJ 320: 788-791
40. Atkinson AJ, Nordstrom K (1996) The challenge of inhospital medication use: an opportunity for clinical pharmacology. Clin Pharmacol Ther 60: 363-367
41. Chertow GM et al. (2001) Guided medication dosing for inpatients with renal insufficiency. JAMA 286: 2839-2844
42. Nightingale PG et al. (2000) Implementation of rules based computerised bedside prescribing and administration: intervention study. BMJ 320: 750-753
43. Hunt DL et al. (1998) Effects of computer-based clinical decision support systems on physician performance and outcomes: a systematic review. JAMA 280: 1339-1346
44. Walton RT et al. (2001) Computerised advice on drug dosage to improve prescribing practice (Cochrane Review). Cochrane Library, Oxford
45. Evans RS et al. (1994) Improving empiric antibiotic selection using computer decision support. Arch Intern Med 154:878-884
46. Evans RS et al. (1998) A computer-assisted management program for antibiotics and other anti-infective agents. N Engl J Med 338: 232-238